Quick Dispatch:
Your glp-1 iih Use of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension : a systematic review | The Journal of Headache and Pain orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp-1 iih Use of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension : a systematic review | The Journal of Headache and Pain ships.
Need Help?
Questions about glp-1 iih Use of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension : a systematic review | The Journal of Headache and Pain, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp-1 iih Use of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension : a systematic review | The Journal of Headache and Pain in your area.
GLP-1 Receptor Agonists Promising in Managing Idiopathic Intracranial Hypertension: JAMA Study
22.69
GLP-1 medications and pseudotumor cerebri / idiopathic intracranial hypertension #pseudotumorcerebri #iih
28.46
Journal club: GLP-1 receptor agonists in idiopathic intracranial hypertension
23.20
Exenatide (a GLP-1 receptor agonist) rapidly lowered intracranial pressure in active IIH, with a sustained signal at 12 weeks and no meaningful weight change. The authors suggest an ICP-lowering
28.08
GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension: A Systematic Review | Headache Journal (Headache: The Journal of Head & Face Pain) posted on the topic
23.52
GLP-1s may manage idiopathic intracranial hypertension
24.76
GLP-1 programs the neurovascular landscape: Cell Metabolism
27.66
